Clinical Trial Update: Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline

View source ↗

Summary

A Tata Memorial Centre study is investigating systemic biomarkers to predict radiation-induced neurocognitive decline in patients with brain tumors, including m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors
• Ependymoma
• Glioma
• Medulloblastoma

Snippet

Sponsor: Tata Memorial Centre | Conditions: Brain Tumors, Medulloblastoma | Status: RECRUITING